Literature DB >> 29656077

Tumor classification with MALDI-MSI data of tissue microarrays: A case study.

Nadine E Mascini1, Jannis Teunissen2, Rob Noorlag3, Stefan M Willems4, Ron M A Heeren5.   

Abstract

With mass spectrometry imaging (MSI) on tissue microarrays (TMAs) a large number of biomolecules can be studied for many patients at the same time, making it an attractive tool for biomarker discovery. Here we investigate whether lymph node metastasis can be predicted from MALDI-MSI data. Measurements are performed on TMAs and then filtered based on spectral intensity and the percentage of tumor cells, after which the resulting data for 122 patients is further preprocessed. We assume differences between patients with and without metastasis are expressed in a limited number of features. Two univariate feature selection methods are applied to reduce the dimensionality of the MALDI-MSI data. The selected features are then used in combination with three classifiers. The best classification scores are obtained with a decision tree classifier, which classifies about 72% of patients correctly. Almost all the predictive power comes from a single peak (m/z 718.4). The sensitivity of our classification approach, which can be generically used to search for biomarkers, is investigated using artificially modified data.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Data analytics; FFPE tissue; Head and neck cancer; MALDI; Mass spectrometry imaging; Tissue microarray

Mesh:

Year:  2018        PMID: 29656077     DOI: 10.1016/j.ymeth.2018.04.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  8 in total

Review 1.  Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Authors:  Matthias Holzlechner; Eliseo Eugenin; Brendan Prideaux
Journal:  Cancer Rep (Hoboken)       Date:  2019-12

2.  Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies.

Authors:  Giulia Capitoli; Isabella Piga; Vincenzo L'Imperio; Francesca Clerici; Davide Leni; Mattia Garancini; Gabriele Casati; Stefania Galimberti; Fulvio Magni; Fabio Pagni
Journal:  Int J Mol Sci       Date:  2022-04-09       Impact factor: 6.208

3.  Effect of MALDI matrices on lipid analyses of biological tissues using MALDI-2 postionization mass spectrometry.

Authors:  Josiah C McMillen; Jarod A Fincher; Dustin R Klein; Jeffrey M Spraggins; Richard M Caprioli
Journal:  J Mass Spectrom       Date:  2020-12       Impact factor: 1.982

4.  Colocalization Features for Classification of Tumors Using Desorption Electrospray Ionization Mass Spectrometry Imaging.

Authors:  Paolo Inglese; Gonçalo Correia; Pamela Pruski; Robert C Glen; Zoltan Takats
Journal:  Anal Chem       Date:  2019-05-01       Impact factor: 6.986

5.  Mass recalibration for desorption electrospray ionization mass spectrometry imaging using endogenous reference ions.

Authors:  Paolo Inglese; Helen Xuexia Huang; Vincen Wu; Matthew R Lewis; Zoltan Takats
Journal:  BMC Bioinformatics       Date:  2022-04-15       Impact factor: 3.307

6.  A Highly Discriminative Hybrid Feature Selection Algorithm for Cancer Diagnosis.

Authors:  Tarneem Elemam; Mohamed Elshrkawey
Journal:  ScientificWorldJournal       Date:  2022-08-09

Review 7.  Applications of MALDI-MS/MS-Based Proteomics in Biomedical Research.

Authors:  Laura Darie-Ion; Danielle Whitham; Madhuri Jayathirtha; Yashveen Rai; Anca-Narcisa Neagu; Costel C Darie; Brînduşa Alina Petre
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

8.  Diagnosis of melanoma by imaging mass spectrometry: Development and validation of a melanoma prediction model.

Authors:  Rami N Al-Rohil; Jessica L Moore; Nathan Heath Patterson; Sarah Nicholson; Nico Verbeeck; Marc Claesen; Jameelah Z Muhammad; Richard M Caprioli; Jeremy L Norris; Sara Kantrow; Margaret Compton; Jason Robbins; Ahmed K Alomari
Journal:  J Cutan Pathol       Date:  2021-07-02       Impact factor: 1.587

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.